• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconJohnson & Johnson

Johnson & Johnson

Page 13 of 18
A judge has ordered the company to pay $572 million in connection with the opioid crisis in Oklahoma
HealthJ&J Shares Rise After Lower Than Expected Award for Company’s Part in Opioid Crisis
By Jef Feeley, Riley Griffin and BloombergAugust 27, 2019
A used syringe in the dirt.
Johnson & Johnson Accused of Dodging Liability for Its Alleged Role in Opioid Epidemic
By Jef Feeley and BloombergJuly 15, 2019
J&J HIV vaccine
HealthJohnson & Johnson to Test a Pioneering HIV Vaccine: Brainstorm Health
By Sy MukherjeeJuly 12, 2019
J&J CEO’s West Point Lesson: Great Leaders Know How to Listen
LeadershipJ&J CEO’s West Point Lesson: Great Leaders Know How to Listen
By Susie GharibApril 17, 2019
Red colored medical pills in a blister pack
HealthXarelto to Become First Prescription Drug With TV Ads That Includes Pricing
By Erik ShermanMarch 29, 2019
Pharmaceutical Company Johnson & Johnson To Pay 4.6 Billion Dollars To 22 Women Over Baby Powder Ovarian Cancer Lawsuit
HealthJury Awards $29 Million in Latest Johnson & Johnson Cancer-Causing Baby Powder Lawsuit
By Brittany ShootMarch 15, 2019
Ajay Royan
FinanceMithril Capital’s Ajay Royan Talks About Working with Peter Thiel and Why ‘Investing Is Hard’
By Rey MashayekhiFebruary 28, 2019
Dow Jones Major Stock Companies
HealthJohnson & Johnson Will Be The First Drug Company To Put Prescription Medication Prices in TV Ads
By Laura Stampler/TIMEFebruary 8, 2019
FRANCE-PHARMACY-MEDICINE-COMPANY-RESEARCH
HealthJohnson & Johnson’s Slowdown Signals a Warning to Health Care Sector
By BloombergJanuary 22, 2019
Pharmaceutical Company Johnson & Johnson To Pay 4.6 Billion Dollars To 22 Women Over Baby Powder Ovarian Cancer Lawsuit
HealthJohnson & Johnson’s $50 Billion Baby Powder Problem Just Got a Whole Lot Worse. Here’s Why
By Lucas LaursenDecember 19, 2018
BRITAIN-PHARMACEUTICAL-GSK
FinanceGlaxo to Split in Two Following Venture Deal with Pfizer
By BloombergDecember 19, 2018
Row of empty chairs in board room
LeadershipCompanies Strike Back, Moonves Fired, China: CEO Daily for December 18, 2018
By Lucas Laursen and Alan MurrayDecember 18, 2018
Company faces potential liability in the millions of dollars.
HealthJohnson & Johnson Knew Baby Powder Contained Asbestos for Decades, Report Claims
By Chris MorrisDecember 14, 2018
Johnson & Johnson CEO Says Fix the Drug Pricing Process, But Not Too Much
LeadershipJohnson & Johnson CEO Says Fix the Drug Pricing Process, But Not Too Much
By Susie GharibDecember 4, 2018
Instagram application
TechAdvertisers Are Giving People With 1,000 Instagram Followers Endorsement Deals
By Laura Stampler/TIMENovember 13, 2018
1...
  • 11
  • 12
  • 13
  • 14
  • 15
...18
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Big Tech
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?placeholder alt text
By Alexei OreskovicApril 29, 2026
AI
‘The cost of compute is far beyond the costs of the employees’: Nvidia executive says right now AI is more expensive than paying human workersplaceholder alt text
By Sasha RogelbergApril 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.